Anglo-Swedish pharmaceuticals firm announces deal for DS-1062, a treatment that targets specific proteins released by tumours
AstraZeneca to buy rights to breakthrough cancer treatment for up to $6bn
Something you may find interesting…
[recent_products per_page="4" columns="4" orderby="rand" order="rand"]